(Circulation. 2001;103:916.)
© 2001 American Heart Association, Inc.
Editorial |
From the Department of Internal Medicine, University of Texas Southwestern Medical Center at Dallas.
Correspondence to Robert L. Johnson, Jr., MD, Pulmonary and Critical Care Division, Department of Internal Medicine, 5323 Harry Hines Blvd, Dallas, TX 75390-9034. E-mail Robert.Johnson{at}utsouthwestern.edu
Key Words: Editorials heart failure ventilation
It has become
increasingly apparent that congestive heart failure (CHF) affects not
only the cardiovascular system, but every organ system involved with
oxygen transport, including the respiratory system, skeletal muscles,
and the hormonal and neural feedback control systems for breathing,
cardiac output, blood pressure, blood volume, and distribution of blood
flow. One segment of this transport system cannot be isolated from the
rest. The ventilatory response to exercise in patients with CHF is
augmented despite normal arterial O2 saturation
and a normal or low end-tidal
PCO2.1 2 3 4 5 6
The augmented ventilatory response is measured as a steep slope of the
increase in ventilation with respect to CO2
output
(
E/
CO2)
or as a high
E/
CO2
ratio at peak exercise. The source of this ventilatory augmentation has
been controversial, but its pathophysiological significance is clear. A
high slope at submaximal exercise or a high
E/
CO2
ratio at peak exercise is a powerful index of poor prognosis in
patients with
CHF.4 7 As
indicated by Ponikowski et
al8 in the current issue of
Circulation, this prognostic
power is retained in patients with CHF, even when the maximal
O2 uptake
(
O2
max) is near the normal range.
A high
E/
CO2
ratio has 2 possible sources: (1) increased ventilation, which is
required to overcome a large dead space to maintain a normal arterial
CO2 tension
(PaCO2),
or (2) increased central drive to ventilation, which drives the
PaCO2
below what is normally expected. Ponikowski et
al8 present convincing
evidence that the augmented ventilatory response to exercise in CHF is
significantly correlated with other markers of abnormal
cardiorespiratory reflex control (ie, central and peripheral
chemoreceptor control of ventilation, ergoreceptor drive to
ventilation, and both autonomic and baroreceptor control of the
circulation). Thus, the high
E/
CO2
seems related to altered chemoreceptor gain and ergoreceptor drive to
ventilation, as well as to impaired reflex control of the heart and
circulation. Impaired autonomic and baroreceptor control become
manifest in severe heart failure by an abnormally reduced variability
in heart rate and an increased variability in blood pressure, with
predisposition to arrhythmias and sudden
death.9 10 These
observations provide a major link between augmented exercise
ventilation in CHF and poor prognosis.
Is the augmented ventilation during exercise an integral
part of the deranged cardiorespiratory reflex controls in CHF or a
manifestation of structural changes in the lung that impair
ventilation/perfusion matching, as I suggested in a previous
editorial?11 Ponikowski et
al8 and
others6 12 from
the same laboratory provide indirect support for a high ventilatory
drive related to increased chemoreceptor gain and ergoreceptor drive in
skeletal muscle. However, if present, such an increased ventilatory
drive should force the
PaCO2
below expected levels during exercise and generate a negative
correlation between
PaCO2
and
E/
CO2
at peak exercise. No convincing data from arterial blood gases indicate
that this occurs. Wasserman et
al5 provided comprehensive
data on alveolar arterial blood gas exchange in 130 patients with CHF
and 52 normal controls. They concluded that "the increase in
ventilatory response in CHF is due primarily to 2 mechanisms: (1) the
increased CO2 output relative to
O2,
owing to bicarbonate buffering of accumulating lactic acid, and (2) the
increase in
VD/VT
ratio due to reduced perfusion of ventilated lung." Arterial
PCO2
was not depressed from rest to heavy exercise, although end-tidal
PCO2
was depressed because of a high alveolar dead space. There was no
evidence for increased central or peripheral drive to
ventilation.
Franciosa et al2
reported both arterial blood gas and hemodynamic data at rest and peak
exercise in 28 patients with CHF. They concluded that "exercise
intolerance in patients with severe CHF is associated with marked
elevation of pulmonary capillary wedge pressure and anaerobic
metabolism without hypoxemia or altered carbon dioxide tension." The
mean
PaCO2
(35±7 mm Hg) was the same at rest and peak exercise; hence, similar
to the data from Wasserman et
al,5 there was no evidence
suggesting a high ventilatory drive. Fortunately, however, Franciosa et
al2 provided the blood gas
and hemodynamic data on each subject in a table, which allowed a more
comprehensive analysis. Both the
E/
CO2
and dead-space gas volume to tidal gas volume
(VD/VT)
ratios can be calculated at peak exercise from the tabulated data and
plotted with respect to
PaCO2
(Figure 1
). This yields a highly significant inverse
correlation between
E/
CO2
and
PaCO2
(Figure 1A
) that supports Ponikowski et
als8 hypothesis. There is
also a highly significant, direct correlation between
E/
CO2
and the
VD/VT
ratio
(Figure 1B
), confirming an uneven distribution of ventilation
with respect to perfusion in the lung. Thus, the
PaCO2
is driven to low levels during peak exercise in CHF, despite
inefficient gas exchange from a high
VD/VT
ratio.
|
From whence might this increased drive arise? Ponikowski et
al8 show high chemoreceptor
gains for
PO2
and
PCO2
in CHF that positively correlate with a high
E/
CO2
slope. Normal individuals who have high chemoreceptor gain also have an
augmented ventilatory response to
exercise.13 14 15
In
Figure 2
, I compare the relationship between
E/
CO2
and
PaCO2
at peak exercise in the CHF patients studied by Franciosa et
al2 with that in the normal
subjects studied by Martin et
al.15 The normal subjects
had different chemoreceptor gains for
PO2
and
PCO2
at rest, which were augmented at exercise; those normal subjects with
high chemoreceptor gains had higher ratios of
E/
CO2
and a lower
PaCO2.
The point of the graph is to illustrate from the regression lines that
that ventilation had to be about twice that in the normal subjects to
achieve the same
PaCO2
because of the inefficient gas exchange (ie, the high
VD/VT
ratio). This means that ventilatory drive had to be, on average, twice
as high in the CHF patients than in the normal subjects studied by
Martin et al.15 It is hard
to explain this increased drive by a simple increase in chemoreceptor
gain, however, because chemoreceptor gain does not represent a
unidirectional drive; rather, it represents the strength of feedback
control to minimize any deviation of arterial
PO2
and
PCO2
in either direction from their respective set points. This is like the
gain of the thermostat in a home air-conditioning system. Exercise must
alter the set point of the control system, perhaps by increased
sympathetic stimulation or from increased stimulation from skeletal
muscle ergoreceptors, both of which are augmented in CHF. A high
chemoreceptor gain would then tighten the control and ensure a smaller
error signal at full response. It would be of interest to know whether
normal subjects who have a high chemoreceptor gain and a high
ventilatory response to exercise also have a high ergoreceptor drive
from skeletal muscle.
|
The augmented ventilatory response to exercise in CHF
correlates with control and reflex abnormalities and with hemodynamic
alterations. The latter relationships can also be illustrated from the
data of Franciosa et al2
(Figure 3
). There is a strong inverse correlation of
E/
CO2
with cardiac index
(Figure 3A
) and with pulmonary artery pressure
(Figure 3B
). Hence, there are multiple reasons why
this simple ratio of
E/
CO2,
or the slope of the increase in
E with respect
to
CO2
during exercise, provides a powerful prognostic index in heart failure.
It seems to reflect the severity of derangement in almost all aspects
of CHF; it is also an objective measurement that can be made
easily.
|
Footnotes
The opinions expressed in this editorial are not necessarily those of the editors or of the American Heart Association.
References
This article has been cited by other articles:
![]() |
L. J. Olson, A. M. Arruda-Olson, V. K. Somers, C. G. Scott, and B. D. Johnson Exercise Oscillatory Ventilation: Instability of Breathing Control Associated With Advanced Heart Failure Chest, February 1, 2008; 133(2): 474 - 481. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Hoeper, M. W. Pletz, H. Golpon, and T. Welte Prognostic value of blood gas analyses in patients with idiopathic pulmonary arterial hypertension Eur. Respir. J., May 1, 2007; 29(5): 944 - 950. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D. Lewis, J. Lachmann, J. Camuso, J. J. Lepore, J. Shin, M. E. Martinovic, D. M. Systrom, K. D. Bloch, and M. J. Semigran Sildenafil Improves Exercise Hemodynamics and Oxygen Uptake in Patients With Systolic Heart Failure Circulation, January 2, 2007; 115(1): 59 - 66. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ciarka, N. Cuylits, J.-L. Vachiery, M. Lamotte, J.-P. Degaute, R. Naeije, and P. van de Borne Increased Peripheral Chemoreceptors Sensitivity and Exercise Ventilation in Heart Transplant Recipients Circulation, January 17, 2006; 113(2): 252 - 257. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Guazzi, G. Reina, G. Tumminello, and M. D. Guazzi Exercise ventilation inefficiency and cardiovascular mortality in heart failure: the critical independent prognostic value of the arterial CO2 partial pressure Eur. Heart J., March 1, 2005; 26(5): 472 - 480. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Guazzi, G. Tumminello, F. Di Marco, C. Fiorentini, and M. D. Guazzi The effects of phosphodiesterase-5 inhibition with sildenafil on pulmonary hemodynamics and diffusion capacity, exercise ventilatory efficiency, and oxygen uptake kinetics in chronic heart failure J. Am. Coll. Cardiol., December 21, 2004; 44(12): 2339 - 2348. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Deboeck, G. Niset, M. Lamotte, J-L. Vachiery, and R. Naeije Exercise testing in pulmonary arterial hypertension and in chronic heart failure Eur. Respir. J., May 1, 2004; 23(5): 747 - 751. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Guazzi, G. Tumminello, M. Matturri, and M. D. Guazzi Insulin ameliorates exercise ventilatory efficiency and oxygen uptake in patients with heart failure-type 2 diabetes comorbidity J. Am. Coll. Cardiol., September 17, 2003; 42(6): 1044 - 1050. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.R. Abraham, L. J. Olson, M. J. Joyner, S. T. Turner, K. C. Beck, and B. D. Johnson Angiotensin-Converting Enzyme Genotype Modulates Pulmonary Function and Exercise Capacity in Treated Patients With Congestive Stable Heart Failure Circulation, October 1, 2002; 106(14): 1794 - 1799. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-S. Poon and R. L. Johnson Jr Possible Mechanism of Augmented Exercise Hyperpnea in Congestive Heart Failure Response Circulation, November 27, 2001; 104 (22): e131 - e131. [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |